How quantum computing can accelerate drug discovery

Beyond Biotech - the podcast from Labiotech

On today’s podcast, Jean-Philip Piquemal, the chief scientific officer and co-founder of Qubit Pharmaceuticals, explains how the company’s Atlas platform is leading the way to more effective and safer drugs.

00:54-01:52: The history of Qubit Pharmaceuticals

01:52-04:04: What is the Atlas software?

04:04-05:18: Failing quickly is the key

05:19-06:53: What are digital twins?

06:54-09:00: Improving safety, reducing costs, and boosting drug discovery

09:00-10:44: Areas of interest

10:44-13:21: Recent successes

13:23-14:57: Preparing for future pandemics

14:58-17:03: Staying ahead of other companies

17:04-18:29: Enough diseases to go around

18:30-20:11: Upgrading Atlas software

20:13-21:59: How Qubit works with pharma companies

21:59-24:41: The Quantum for Bio program

24:42-27:58: Looking to the future, and helping patients

Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

Chapters

1. How quantum computing can accelerate drug discovery (00:00:00)

2. The history of Qubit Pharmaceuticals (00:00:54)

3. What is the Atlas software? (00:01:52)

4. Failing quickly is the key (00:04:04)

5. What are digital twins? (00:05:19)

6. Improving safety, reducing costs, and boosting drug discovery (00:06:54)

7. Areas of interest (00:09:00)

8. Recent successes (00:10:44)

9. Preparing for future pandemics (00:13:23)

10. Staying ahead of other companies (00:14:58)

11. Enough diseases to go around (00:17:04)

12. Upgrading Atlas software (00:18:30)

13. Working with pharma companies (00:20:13)

14. The Quantum for Bio program (00:21:59)

15. Looking to the future (00:24:42)